Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer by Yuanyuan Wang, Chenxi Hu, Tianpeng Du, Jiawen Li, Kaiyuan Hui, Xiaodong Jiang

Subjects: Get full text

Skin Tumors Diagnosis Utilizing Case Based Reasoning and The Expert System by Roza Fuad Majeed, Soran AB. M. Saeed, Dana Abdulmajeed Abdilkarim, Haval Mohammed Sidqi

Subjects: “…Keywords: Skin cancer, BCC, SCC, melanoma, CBR, expert system.…”
Get full text

تعیین نوع سیال و سنگ‌شناسی یکی از مخازن ناهمگن در شمال غرب خلیج‌فارس با استفاده از روش AVO و جانشینی سیال by سپیده یاسمی خیابانی, سجاد قره چلو, مهران کلهری, ابراهیم الیاسی

Subjects: Get full text

Capital de risco e gerenciamento de resultados em IPOs by Sabrina P. Ozawa Gioiellii, Antônio Gledson de Carvalho, Joelson Oliveira Sampaio

Subjects: Get full text

Benefits of Gardenia jasminoides Ellis’s floral volatile components on human emotions and moods by Yan Cai, Hannan Chen, Xin Zhang, Wanning Bu, Wei Ning

Subjects: Get full text

Comunicación familiar y toma de decisiones en sexualidad entre ascendientes y adolescentes by Valentina González, Linda Teresa Orcasita, Juan Pablo Carrillo, Diana Marcela Palma-García

Subjects: “…toma de decisiones (thesaurus decs)…”
Get full text

Identification of the primary pollution sources and dominant influencing factors of soil heavy metals using a random forest model optimized by genetic algorithm coupled with geodet... by Tong Liu, Mingshi Wang, Mingya Wang, Qinqing Xiong, Luhao Jia, Wanqi Ma, Shaobo Sui, Wei Wu, Xiaoming Guo

Subjects: “…APCS-MLR…”
Get full text

Peach Consumption: A Profile of Purchasers and Non-Purchasers by Joy N. Rumble, Kara Harders, Kathryn Stofer

Subjects: “…WC288…”
Get full text

Peach Consumption: A Profile of Purchasers and Non-Purchasers by Joy N. Rumble, Kara Harders, Kathryn Stofer

Subjects: “…WC288…”
Get full text

Trends in prevalence and disability-adjusted life years for refractive disorders in China and globally from 1990 to 2021: an analysis of the Global Burden of Disease Study 2021 by Fangfang Lai, Hongfang Xia, Liang Wang

Subjects: Get full text

Multiclass Supervised Learning Approach for SAR-COV2 Severity and Scope Prediction: SC2SSP Framework by Shaik Khasim Saheb, B. Narayanan, T.V. Narayana Rao

Subjects: Get full text

Dianchonair Fhéideartha an Inspreagtha in Oideachas Múinteoirí an Tumoideachais [Potential Powerful Pathways of Motivation in Immersion Teacher Education] by Caoileann Ní Dhonnchadha, Karen Ní Chlochasaigh, T.J. Ó Ceallaigh

Subjects: “…Directed Motivational Current (DMC)…”
Get full text

Florida’s Agritourism Laws by Mary Beth Henry, Kathryn A. Stofer

Subjects: “…WC285…”
Get full text

USE OF GEOINFORMATION TECHNOLOGIES IN DISTANCE LEARNING OF FUTURE SPECIALISTS IN GEOGRAPHY by Vasyl V. Leta, Mykola M. Karabiniuk, Mykhailo M. Mykyta, Mykhailo M. Kachailo

Subjects: Get full text

Florida’s Agritourism Laws by Mary Beth Henry, Kathryn A. Stofer

Subjects: “…WC285…”
Get full text

Distinctive blood and salivary proteomics signatures in Qatari individuals at high risk for cardiovascular disease by Ghada Yousif, Selvasankar Murugesan, Mohamed Nadhir Djekidel, Annalisa Terranegra, Giusy Gentilcore, Jean Charles Grivel, Souhaila Al Khodor

Subjects: Get full text

Application of Data Clustering Embedded in Fuzzy Classifier Expert System for Water Quality Recognition by JC Obi, AA Imianvan

“…@JASEM Keywords: Fuzzy classifier, fuzzy logic, fuzzy set, Water J. Appl. Sci. Environ. Manage. Sept, 2011, Vol. 15 (3) 523 - 529…”
Get full text

Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial by David Malka, Philippe Laramée, Mondher Toumi, Jean-Baptiste Trouiller, Bérengère Macabeo, Andrew Poll, Dan Howard, Andy Buckland, Marine Sivignon, Emilie Clay, Emmanuelle Samalin

“…Encorafenib with cetuximab was considered cost-effective compared with the three comparators at a willingness to pay threshold of €90 000/QALY, with probabilities of being cost-effective of 89.8%, 98.2% and 86.4%, respectively.Conclusions This analysis showed encorafenib with cetuximab to be a cost-effective treatment in mCRC patients with a BRAF V600E mutation.…”
Get full text